Adolescent Results Put Pfizer/BioNTech Ahead Of COVID Vaccine Pack, For Now
Hoping For EUA Before Start Of School Year
An EUA would carve out a market advantage, although Moderna should be releasing similar data soon for its COVID-19 vaccine.
You may also be interested in...
The companies still plan to develop a variant-specific version, while J&J said it anticipates meeting vaccine supply goals despite a manufacturing mix-up.
Success of the vaccine will fuel the company’s push into immunotherapy, as it reported first commercial sales.
A rush of additional orders from countries around the world has boosted the company’s prospects, and fueled its ambitions beyond COVID-19.